- Home
- ALV vs LNTH Comparison
ALV vs LNTH Comparison
Compare ALV & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALV | LNTH |
|---|---|---|
| Founded | 1953 | 1956 |
| Country | Sweden | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.7B | 4.4B |
| IPO Year | 1997 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ALV | LNTH |
|---|---|---|
| Price | $123.24 | $69.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 6 |
| Target Price | ★ $133.45 | $78.00 |
| AVG Volume (30 Days) | 463.2K | ★ 1.1M |
| Earning Date | 01-30-2026 | 02-25-2026 |
| Dividend Yield | ★ 2.72% | N/A |
| EPS Growth | ★ 25.57 | N/A |
| EPS | ★ 9.69 | 2.39 |
| Revenue | ★ $10,614,000,000.00 | $1,525,933,000.00 |
| Revenue This Year | $4.71 | $0.01 |
| Revenue Next Year | $4.08 | $0.52 |
| P/E Ratio | ★ $12.92 | $29.12 |
| Revenue Growth | 0.85 | ★ 1.95 |
| 52 Week Low | $75.49 | $47.25 |
| 52 Week High | $129.54 | $111.29 |
Technical Indicators
Market Signals| Indicator | ALV | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | 57.93 | 68.66 |
| Support Level | $118.10 | $66.36 |
| Resistance Level | $121.53 | $67.45 |
| Average True Range (ATR) | 1.80 | 1.67 |
| MACD | 0.40 | -0.01 |
| Stochastic Oscillator | 66.98 | 82.27 |
Price Performance
Historical ComparisonAbout ALV Autoliv Inc.
Autoliv Inc is the world-wide leader in passive safety components and systems for the auto industry. Products include seat belts, frontal air bags, side-impact air bags, air bag inflators, and steering wheels. The Renault-Nissan-Mitsubishi alliance is the company's largest customer at 10% of 2023 revenue, with Stellantis accounting for 10% and Volkswagen 9%. At 34% of 2023 revenue, the Americas was Autoliv's largest geographic region, followed by Europe at 27%, China at 20%, and rest of world at 19%.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.